Enhancement of 5-hydroxytryptamine-induced head-twitch response after olfactory bulbectomy

Neuroscience

Volumn 117, Issue 4, 2003, Pages 1017-1023

  Nakagawasai, O ^a   Tadano, T ^a   Arai, Y ^b   Hozumi, S ^a   Oba, A ^a   Tan No, K ^a   Yasuhara, H ^b   Kisara, K ^a   Oreland, L ^c  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

5 HT2 receptor; 5 hydroxytryptamine uptake; MAO; Monoamine oxidase; Olfactory bulbectomized

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; KETANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; FOREBRAIN; HEAD TWITCH; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE PROJECTION; NONHUMAN; OLFACTORY BULBECTOMY; PRECURSOR; PRIORITY JOURNAL; SEROTONIN UPTAKE;

EID: 0037430752     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00788-1     Document Type: Article

References (49)

1. Arai Y., Stenstrom A., Oreland L. The effect of age on intra- and extraneuronal monoamine oxidase-A and -B activities in the rat brain. Biogenic Amines. 2:1985;65-71.
2. Arai Y. Influence of diabetes on monoamine oxidase in rat brain. Biogenic Amines. 8:1992;413-420.
3. Bach A.W., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E., Kwan S.-W., Seeburg P.H., Shih J.C. cDNA cloning of human liver monoamine oxidase A and B Molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA. 85:1988;4934-4938.
4. 2 receptor subtypes A family re-united? Trends Pharmacol Sci. 16:1995;105-110.
5. Bedard P., Pycock C.J. "Wet-dog" shake behaviour in the rat A possible quantitative model of central 5-hydroxytryptamine activity . Neuropharmacology. 16:1977;663-670.
6. Bill D.J., Knight M., Forster E.A., Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT induced hypothermia. Br J Pharmacol. 103:1991;1857-1864.
7. Brittain R.T., Handley S.L. Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J Physiol. 192:1967;805-813.
8. Butler J., Tannian M., Leonard B.E. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats. Prog Neuropsychopharmacol Biol Psychiatry. 12:1988;585-594.
9. Cain D.P. The role of the olfactory bulb in limbic mechanisms. Psychol Bull. 81:1974;654-671.
10. Carlsson A., Fowler C.J., Magnusson T., Oreland L., Wiberg A. The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection. Naunyn Schmiedebergs Arch Pharmacol. 316:1981;51-55.
11. 2A receptors in 5-fluoro-α-methyltryptamine- induced head-twitch responses of mice. Br J Pharmacol. 123:1998;855-862.
12. Corne S.J., Pickering R.W., Warner B.T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol. 20:1963;106-120.
13. De Almeida R.M., Lucion A.B. Effects of intracerebroventricular administration of 5-HT receptor agonists on the maternal aggression of rats. Eur J Pharmacol. 264:1994;445-448.
14. Earley B., Glennon M., Lally M., Leonard B.E., Junien J.L. Autoradiographic distribution of cholinergic muscarinic receptors and serotonin (2) receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine. Hum Psychopharmacol. 9:1994;397-407.
15. Gartside S.E., Cowen P.J., Sharp T. Effect of 5-hydroxy-L-tryptophan on the release of 5- HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology. 31:1992;9-14.
16. Glennon RA, Dukat M, Westkaemper RB (1999) Serotonin receptors and ligands. In: Psychopharmacology: The fourth generation of progress: CD-ROM (Bloom FE, Kupfer DF, eds). New York: Raven Press.
17. 2 receptors. Br J Pharmacol. 84:1985;743-753.
18. Hall R.D., Macrides F. Olfactory bulbectomy impairs the rat's radial-maze behavior. Physiol Behav. 30:1983;797-803.
19. 2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. Brain Res Mol Brain Res. 54:1998;199-211.
20. Hartvig P., Tedroff J., Lindner K.J., Bjurling P., Chang C.-W., Tsukada H., Watanabe Y., Langstrom B. Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brain. J Neural Transm Gen Sect. 94:1993;127-135.
21. 2 receptors. Neuropharmacology. 24:1985;1201-1205.
22. 2 sites in cortex and amygdala . Brain Res. 614:1993;37-44.
23. Jancsar S.M., Leonard B.E. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 8:1984;263-269.
24. Kelly J.P., Leonard B.E. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33:1994;1011-1016.
25. Kelly J.P., Wrynn A.S., Leonard B.E. The olfactory bulbectomized rat as a model of depression An update . Pharmacol Ther. 74:1997;299-316.
26. Larsson K. Impaired mating performances in male rats after anosmia induced peripherally or centrally. Brain Behav Evol. 4:1971;463-471.
27. Lucki I., Nobler M.S., Frazer A. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther. 228:1984;133-139.
28. Lumia A.R., Teicher M.H., Salchli F., Ayers E., Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587:1992;181-185.
29. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
30. Marcilhac A., Faudon M., Anglade G., Hery F., Siaud P. An investigation of serotonergic involvement in the regulation of ACTH and corticosterone in the olfactory bulbectomized rat. Pharmacol Biochem Behav. 63:1999;599-605.
31. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 87:1978;206-210.
32. McGrath C., Kelly J.P., McHugh M.F., Leonard B.E. Effect of acute administration of 3,4-methylenedioxymethamphetamine (MDMA) on temperature and locomotor activity in the olfactory bulbectomised rat model of depression. Med Sci Res. 23:1995;119-120.
33. 2 receptors in chronic schizophrenics. Biol Psychiatry. 21:1986;1407-1414.
34. Neckers L.M., Zarrow M.X., Myers M.M., Denenberg V.H. Influence of olfactory bulbectomy and the serotonergic system upon intermale aggression and maternal behavior in the mouse. Pharmacol Biochem Behav. 3:1975;545-550.
35. Neff N.H., Yang N.Y. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci. 14:1974;2061-2074.
36. Oreland L., Arai Y., Stenstrom A. Age, neuro-psychiatric diseases and brain monoamine oxidase. Tipton K.F., Dostert P., Strolin, Benedetti M. Monoamine oxidase and disease. 1984;291-300 Academic Press, London.
37. Oreland L., Hallman J. The correlation between platelet MAO activity and personality Short review of findings and a discussion on possible mechanisms . Prog Brain Res. 106:1995;77-84.
38. Redmond A.M., Kelly J.P., Leonard B.E. Effect of paroxetine and fluvoxamine on behavioural changes in a number of paradigms in the olfactory bulbectomized rat model of depression. J Serotonin Res. 1:1994;199-205.
39. Roth B.L. Multiple serotonin receptors Clinical and experimental aspects . Ann Clin Psychiatry. 6:1994;67-78.
40. Sakurada T., Kisara K. Effects of p-chlorophenylalanine (p-CPA) on sleep in olfactory bulb lesioned rats. Jpn J Pharmacol. 27:1977;389-395.
41. Sandberg M., Bradford H.F., Richards C.D. Effect of lesions of the olfactory bulb on the levels of amino acids and related enzymes in the olfactory cortex of the guinea pig. J Neurochem. 43:1984;276-279.
42. Sieck M.H. The role of the olfactory system in avoidance learning and activity. Physiol Behav. 8:1972;705-710.
43. Song C., Leonard B.E. The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function. Hum Psychopharmacol. 10:1995;7-18.
44. Stenstrom A., Arai Y., Oreland L. Intra- and extraneuronal monoamine oxidase-A and -B activities after central axotomy (hemisection) on rats. J Neural Transm. 61:1985;105-113.
45. Tadano T., Satoh S., Satoh N., Kisara K., Arai Y., Kim S.K., Kinemuchi H. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. J Pharmacol Exp Ther. 250:1989;254-260.
46. Tadano T., Neda M., Hozumi M., Yonezawa A., Arai Y., Fujita T., Kinemuchi H., Kisara K. Alpha-methylated tryptamine derivatives induce a 5-HT receptor-mediated head-twitch response in mice. Neuropharmacology. 34:1995;229-234.
47. Tipton K.F. Monoamine oxidase inhibition. Biochem Soc Trans. 22:1994;764-768.
48. Van Rijzingen I.M., Gispen W.H., Spruijt B.M. Olfactory bulbectomy temporarily impairs Morris maze performance An ACTH (4-9) analog accelerates return of function . Physiol Behav. 58:1995;147-152.
49. 2 receptor changes in major depression. Biol Psychiatry. 27:1990;489-496.